Jasmeet Kaur
Roswell Park Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jasmeet Kaur as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:05 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06202066 · Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine CarcinomasRoswell Park Cancer Institute · not yet recruiting · Digestive System Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm, Malignant Solid Neoplasm · principal investigator
- Ph1NCT03879694 · Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine TumorsRoswell Park Cancer Institute · completed · Lung Atypical Carcinoid Tumor, Lung Typical Carcinoid Tumor, Metastatic Pancreatic Neuroendocrine Tumor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:05 UTC. The ranking covers the 200 most relevant of 78 PubMed records, and a shared surname and initials can bring in a namesake. All 78 on PubMed
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.N Engl J Med · 2016509 citationsRCR 16.8
- 254 citationsRCR 5.7
- Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.Clin Cancer Res · 2000238 citationsRCR 4.3
- 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial.JACC Cardiovasc Interv · 2020229 citationsRCR 14.3
- Antioxidant status in rheumatoid arthritis and role of antioxidant therapy.Clin Chim Acta · 2003165 citationsRCR 4.7
- 157 citationsRCR 4.7
- 154 citationsRCR 3.1
- Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.J Clin Oncol · 1997137 citationsRCR 3.5
- Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry.JACC Cardiovasc Interv · 2018121 citationsRCR 6.0
- A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma.Am J Clin Oncol · 200789 citationsRCR 1.9